Accuron Technologies plans to further develop its suite of medical devices outsourcing services through its recent acquisition of a majority stake in Aurum Healthcare, a provider of sterilisation services for medical devices and instruments.

"Nantong Jinghua Pharma will become a 78.3% stakeholder in Jiangsu Kingsley Pharmaceuticals."

According to the agreement, Accuron Technologies will place Aurum Healthcare under its Advanced Materials Technologies (AMT) business in order to increase AMT’s manufacturing footprint.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Nantong Jinghua Pharma, a Chinese traditional pharma products manufacturer, plans to acquire an additional 29.73% stake in Jiangsu Kingsley Pharmaceuticals.

Following the transaction, Nantong Jinghua Pharma will become a 78.3% stakeholder in Jiangsu Kingsley Pharmaceuticals.

Clinical Trials Arena Excellence Awards - Nominations Closed

Nominations are now closed for the Clinical Trials Arena Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Science 37 has won the Research and Development Award in the Site Innovation category for its FDA inspected Direct-to-Patient Site model, delivering nationwide access, faster enrollment and higher retention. Explore how its virtual-first, in home approach is reshaping trial operations and accelerating time to data-driven decisions..

Discover the Impact